An exploratory identification of biological markers of chronic musculoskeletal pain in the low back, neck, and shoulders

Codjo Djignefa Djade, Caroline Diorio, Danielle Laurin, Clermont E Dionne, Codjo Djignefa Djade, Caroline Diorio, Danielle Laurin, Clermont E Dionne

Abstract

Objectives: This study was an in-depth exploration of unique data from a nationally representative sample of adults living in the United States to identify biomarkers associated with musculoskeletal pain.

Methods: We performed secondary analyses of 2003-2004 NHANES data. After a first screening of 187 markers, analyses of 31 biomarkers were conducted on participants aged ≥20 years identified in all counties using the 2000 Census Bureau data (n = 4,742). To assess the association of each biomarker with each pain outcome (acute, subacute and chronic low back, neck, and shoulder pain), analyses were carried out using multivariable logistic regression with adjustments for sex, age and body mass index. Biomarkers were considered as continuous variables and categorized at the median of their distributions.

Results: Pain at any site for ≥24 hours during the past month was reported by 1,214 participants. Of these, 779 mentioned that the pain had lasted for ≥3 months ("chronic pain"). α-carotene, ascorbic acid, β-carotene, mercury and total protein had a statistically significant, inverse association with ≥2 chronic pain sites. Acrylamide, alkaline phosphatase, cadmium, cotinine, glycidamide, homocysteine, retinol, triglycerides and white blood cell count were positively associated with ≥2 chronic pain sites. Few biological markers were associated with acute and subacute pain.

Conclusions: This study identified some biomarkers that were strongly and consistently associated with musculoskeletal pain. These results raise new hypotheses and could have tremendous implications for advancing knowledge in the field. Research on musculoskeletal pain needs to put more effort on the biological dimension of the biopsychosocial model of pain.

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1. Selection of study participants.
Fig 1. Selection of study participants.
N.B: The number of participants with pain includes all pain sites included in NHANES 2003–2004. The question on pain includes all sites of musculoskeletal pain (shoulder, arm, low back, leg, neck, spine, hand, foot…).

References

    1. Hoy DG, Smith E, Cross M, Sanchez-Riera L, Buchbinder R, Blyth FM, et al.. The global burden of musculoskeletal conditions for 2010: an overview of methods. Ann Rheum Dis. 2014;73(6):982–9. Epub 2014/02/20. doi: 10.1136/annrheumdis-2013-204344 .
    1. Maher C, Underwood M, Buchbinder R. Non-specific low back pain. Lancet. 2017;389(10070):736–47. doi: 10.1016/S0140-6736(16)30970-9 .
    1. Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, et al.. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2197–223. doi: 10.1016/S0140-6736(12)61689-4 .
    1. Hoy D, March L, Brooks P, Blyth F, Woolf A, Bain C, et al.. The global burden of low back pain: estimates from the Global Burden of Disease 2010 study. Ann Rheum Dis. 2014;73(6):968–74. doi: 10.1136/annrheumdis-2013-204428 .
    1. Waddell G. 1987 Volvo award in clinical sciences. A new clinical model for the treatment of low-back pain. Spine (Phila Pa 1976). 1987;12(7):632–44. Epub 1987/09/01. doi: 10.1097/00007632-198709000-00002 .
    1. Buchbinder R, van Tulder M, Oberg B, Costa LM, Woolf A, Schoene M, et al.. Low back pain: a call for action. Lancet. 2018;391(10137):2384–8. doi: 10.1016/S0140-6736(18)30488-4 .
    1. Puntmann VO. How-to guide on biomarkers: biomarker definitions, validation and applications with examples from cardiovascular disease. Postgrad Med J. 2009;85(1008):538–45. Epub 2009/10/01. doi: 10.1136/pgmj.2008.073759 .
    1. Johnson CL, Paulose-Ram R, Ogden CL, Carroll MD, Kruszon-Moran D, Dohrmann SM, et al.. National health and nutrition examination survey: analytic guidelines, 1999–2010. Vital Health Stat 2. 2013;(161):1–24. Epub 2014/08/05. .
    1. Ahluwalia N, Dwyer J, Terry A, Moshfegh A, Johnson C. Update on NHANES Dietary Data: Focus on Collection, Release, Analytical Considerations, and Uses to Inform Public Policy. Adv Nutr. 2016;7(1):121–34. Epub 2016/01/17. doi: 10.3945/an.115.009258 .
    1. Curtin LR, Mohadjer LK, Dohrmann SM, Montaquila JM, Kruszan-Moran D, Mirel LB, et al.. The National Health and Nutrition Examination Survey: Sample Design, 1999–2006. Vital Health Stat 2. 2012;(155):1–39. Epub 2012/07/14. .
    1. Treede RD, Rief W, Barke A, Aziz Q, Bennett MI, Benoliel R, et al.. Chronic pain as a symptom or a disease: the IASP Classification of Chronic Pain for the International Classification of Diseases (ICD-11). Pain. 2019;160(1):19–27. doi: 10.1097/j.pain.0000000000001384 .
    1. Elliott AM, Smith BH, Penny KI, Smith WC, Chambers WA. The epidemiology of chronic pain in the community. Lancet. 1999;354(9186):1248–52. doi: 10.1016/s0140-6736(99)03057-3 .
    1. Blyth FM, Briggs AM, Schneider CH, Hoy DG, March LM. The Global Burden of Musculoskeletal Pain-Where to From Here? Am J Public Health. 2019;109(1):35–40. Epub 2018/11/30. doi: 10.2105/AJPH.2018.304747 .
    1. NHANES, NHANES 2003–2004 Laboratory Methods, . In view of Oct. 2020.
    1. Douketis JD, Paradis G, Keller H, Martineau C. Canadian guidelines for body weight classification in adults: application in clinical practice to screen for overweight and obesity and to assess disease risk. CMAJ. 2005;172(8):995–8. Epub 2005/04/13. doi: 10.1503/cmaj.045170 .
    1. Flegal KM, Kit BK, Orpana H, Graubard BI. Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA. 2013;309(1):71–82. Epub 2013/01/03. doi: 10.1001/jama.2012.113905 .
    1. Centers for Disease Control and Prevention (CDC). National Center for Health Statistics (NCHS). Examination Survey Analytic and Reporting Guidelines. Hyattsville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Sept. 2006. (cited Oct. 20, 2010). CDC/National Center for Health Statistics; 2006.
    1. SAS Institute Inc. The SAS System for Sun OS. Cary NSII.
    1. Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiology. 1990;1(1):43–6. Epub 1990/01/01. .
    1. Rubin M. When to Adjust Alpha During Multiple Testing: A Consideration of Disjunction, Conjunction, and Individual Testing. Synthese 2021. doi: 10.1007/s11229-021-03276-4
    1. van den Berg R, Jongbloed EM, de Schepper EIT, Bierma-Zeinstra SMA, Koes BW, Luijsterburg PAJ. The association between pro-inflammatory biomarkers and nonspecific low back pain: a systematic review. Spine J. 2018;18(11):2140–51. Epub 2018/07/01. doi: 10.1016/j.spinee.2018.06.349 .
    1. Croft P, Jordan K, Jinks C. "Pain elsewhere" and the impact of knee pain in older people. Arthritis Rheum. 2005;52(8):2350–4. doi: 10.1002/art.21218 .
    1. Natvig B, Bruusgaard D, Eriksen W. Localized low back pain and low back pain as part of widespread musculoskeletal pain: two different disorders? A cross-sectional population study. J Rehabil Med. 2001;33(1):21–5. doi: 10.1080/165019701300006498
    1. Thomas E, Silman AJ, Croft PR, Papageorgiou AC, Jayson MI, Macfarlane GJ. Predicting who develops chronic low back pain in primary care: a prospective study. Bmj. 1999;318(7199):1662–7. doi: 10.1136/bmj.318.7199.1662
    1. Batista ED, Andretta A, de Miranda RC, Nehring J, Dos Santos Paiva E, Schieferdecker ME. Food intake assessment and quality of life in women with fibromyalgia. Rev Bras Reumatol Engl Ed. 2016;56(2):105–10. Epub 2016/06/09. doi: 10.1016/j.rbre.2015.08.015 .
    1. Cao WT, Zeng FF, Li BL, Lin JS, Liang YY, Chen YM. Higher dietary carotenoid intake associated with lower risk of hip fracture in middle-aged and elderly Chinese: A matched case-control study. Bone. 2018;111:116–22. doi: 10.1016/j.bone.2018.03.023 .
    1. Hayhoe RPG, Lentjes MAH, Mulligan AA, Luben RN, Khaw KT, Welch AA. Carotenoid dietary intakes and plasma concentrations are associated with heel bone ultrasound attenuation and osteoporotic fracture risk in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Norfolk cohort. Br J Nutr. 2017;117(10):1439–53. Epub 2017/06/08. doi: 10.1017/S0007114517001180 .
    1. Baineni R, Gulati R, Delhi CK. Vitamin A toxicity presenting as bone pain. Arch Dis Child. 2017;102(6):556–8. Epub 2016/06/09. doi: 10.1136/archdischild-2016-310631 .
    1. Penniston KL, Tanumihardjo SA. The acute and chronic toxic effects of vitamin A. Am J Clin Nutr. 2006;83(2):191–201. Epub 2006/02/14. doi: 10.1093/ajcn/83.2.191 .
    1. Karaosmanoglu N, Mulkoglu C. Analysis of musculoskeletal side effects of oral Isotretinoin treatment: a cross-sectional study. BMC Musculoskelet Disord. 2020;21(1):631. Epub 2020/09/27. doi: 10.1186/s12891-020-03656-w .
    1. Abdullah M, Jamil RT, Attia FN. Vitamin C (Ascorbic Acid). StatPearls. Treasure Island (FL)2020.
    1. Dionne CE, Laurin D, Desrosiers T, Abdous B, Le Sage N, Frenette J, et al.. Serum vitamin C and spinal pain: a nationwide study. Pain. 2016;157(11):2527–35. Epub 2016/10/19. doi: 10.1097/j.pain.0000000000000671 .
    1. Faroon O, Ashizawa A, Wright S, Tucker P, Jenkins K, Ingerman L, et al. Toxicological Profile for Cadmium. Agency for Toxic Substances and Disease Registry (ATSDR) Toxicological Profiles. Atlanta (GA)2012.
    1. La-Up A, Wiwatanadate P, Uthaikhup S, Pruenglampoo S. Association between urinary cadmium and chronic musculoskeletal pain in residents of cadmium-contaminated area in Northwest Thailand. Environ Sci Pollut Res Int. 2018;25(14):14182–7. Epub 2018/03/11. doi: 10.1007/s11356-018-1665-3 .
    1. Satarug S, Garrett SH, Sens MA, Sens DA. Cadmium, environmental exposure, and health outcomes. Cien Saude Colet. 2011;16(5):2587–602. Epub 2011/06/10. doi: 10.1590/s1413-81232011000500029 .
    1. Inaba T, Kobayashi E, Suwazono Y, Uetani M, Oishi M, Nakagawa H, et al.. Estimation of cumulative cadmium intake causing Itai-itai disease. Toxicol Lett. 2005;159(2):192–201. Epub 2005/07/12. doi: 10.1016/j.toxlet.2005.05.011 .
    1. Lee YH, Scharnitz TP, Muscat J, Chen A, Gupta-Elera G, Kirby JS. Laboratory Monitoring During Isotretinoin Therapy for Acne: A Systematic Review and Meta-analysis. JAMA Dermatol. 2016;152(1):35–44. Epub 2015/12/03. doi: 10.1001/jamadermatol.2015.3091 .
    1. Polat M, Lenk N, Bingol S, Oztas P, Ilhan MN, Artuz F, et al.. Plasma homocysteine level is elevated in patients on isotretinoin therapy for cystic acne: a prospective controlled study. J Dermatolog Treat. 2008;19(4):229–32. doi: 10.1080/09546630701846079 .
    1. Guallar E, Silbergeld EK, Navas-Acien A, Malhotra S, Astor BC, Sharrett AR, et al.. Confounding of the relation between homocysteine and peripheral arterial disease by lead, cadmium, and renal function. Am J Epidemiol. 2006;163(8):700–8. doi: 10.1093/aje/kwj090 .
    1. Kang MY, Cho SH, Lim YH, Seo JC, Hong YC. Effects of environmental cadmium exposure on liver function in adults. Occup Environ Med. 2013;70(4):268–73. doi: 10.1136/oemed-2012-101063 .
    1. Ma S, Zhang J, Xu C, Da M, Xu Y, Chen Y, et al.. Increased serum levels of cadmium are associated with an elevated risk of cardiovascular disease in adults. Environ Sci Pollut Res Int. 2021. doi: 10.1007/s11356-021-15732-2 .
    1. Karakaya A, Yucesoy B, Sardas OS. An immunological study on workers occupationally exposed to cadmium. Hum Exp Toxicol. 1994;13(2):73–5. Epub 1994/02/01. doi: 10.1177/096032719401300202 .
    1. Lovasova E, Racz O, Cimbolakova I, Novakova J, Dombrovsky P, Nistiar F. Effects of chronic low-dose cadmium exposure on selected biochemical and antioxidant parameters in rats. J Toxicol Environ Health A. 2013;76(17):1033–8. doi: 10.1080/15287394.2013.828249 .
    1. Samarghandian S, Azimi-Nezhad M, Shabestari MM, Azad FJ, Farkhondeh T, Bafandeh F. Effect of chronic exposure to cadmium on serum lipid, lipoprotein and oxidative stress indices in male rats. Interdiscip Toxicol. 2015;8(3):151–4. Epub 2016/08/04. doi: 10.1515/intox-2015-0023 .
    1. Ireland P, Jolley D, Giles G, Powles J, O’Dea K, Hopper J, et al.. Determinants of serum levels of retinol, beta-carotene and alpha-tocopherol in men and women born in Australia, Greece and Italy. Asia Pac J Clin Nutr. 1994;3(4):169–77. .
    1. Rogalska J, Brzoska MM, Roszczenko A, Moniuszko-Jakoniuk J. Enhanced zinc consumption prevents cadmium-induced alterations in lipid metabolism in male rats. Chem Biol Interact. 2009;177(2):142–52. Epub 2008/10/14. doi: 10.1016/j.cbi.2008.09.011 .
    1. Carter JA, Desai SM, Probst J, Kogan M. Integrative Medicine Approach To Peripheral Neuropathy-Avoiding Pitfalls Of Ineffective Current Standards In Assessing Chronic Low-Grade Mercury Toxicity And Functional Musculoskeletal Lesions. Integr Med (Encinitas). 2019;18(5):49–55. Epub 2020/06/19. .
    1. Masur LC. A review of the use of mercury in historic and current ritualistic and spiritual practices. Altern Med Rev. 2011;16(4):314–20. Epub 2012/01/05. .
    1. Kroger E, Verreault R, Carmichael PH, Lindsay J, Julien P, Dewailly E, et al.. Omega-3 fatty acids and risk of dementia: the Canadian Study of Health and Aging. Am J Clin Nutr. 2009;90(1):184–92. Epub 2009/05/29. doi: 10.3945/ajcn.2008.26987 .
    1. Petrova MV, Ourgaud M, Boavida JRH, Dufour A, Tesan Onrubia JA, Lozingot A, et al.. Human mercury exposure levels and fish consumption at the French Riviera. Chemosphere. 2020;258:127232. Epub 2020/06/17. doi: 10.1016/j.chemosphere.2020.127232 .
    1. Jarvis MJ, Russell MA, Benowitz NL, Feyerabend C. Elimination of cotinine from body fluids: implications for noninvasive measurement of tobacco smoke exposure. Am J Public Health. 1988;78(6):696–8. doi: 10.2105/ajph.78.6.696
    1. Dionne CE, Laurin D, Desrosiers T, Abdous B, Le Sage N, Frenette J, et al.. Vitamin C is not the Missing Link Between Cigarette Smoking and Spinal Pain. Spine (Phila Pa 1976). 2018;43(12):E712–E21. Epub 2017/12/15. doi: 10.1097/BRS.0000000000002466 .
    1. Spencer PS, Schaumburg HH. Nervous system degeneration produced by acrylamide monomer. Environ Health Perspect. 1975;11:129–33. Epub 1975/06/01. doi: 10.1289/ehp.7511129
    1. Pruser KN F N. Acrylamide in health and disease. Front Biosci (Schol Ed). 2011;3:41–51. Epub Epub 2011/01/05. doi: 10.2741/s130 .
    1. Dionne CE, Dunn KM, Croft PR, Nachemson AL, Buchbinder R, Walker BF, et al.. A consensus approach toward the standardization of back pain definitions for use in prevalence studies. Spine (Phila Pa 1976). 2008;33(1):95–103. Epub 2008/01/01. doi: 10.1097/BRS.0b013e31815e7f94 .
    1. Griffith LE, Hogg-Johnson S, Cole DC, Krause N, Hayden J, Burdorf A, et al.. Low-back pain definitions in occupational studies were categorized for a meta-analysis using Delphi consensus methods. J Clin Epidemiol. 2007;60(6):625–33. Epub 2007/05/12. doi: 10.1016/j.jclinepi.2006.09.005 .

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren